HomeNDOI • OTCMKTS
add
Endo Inc
Previous close
$23.52
Day range
$23.52 - $23.55
Year range
$22.50 - $29.75
Market cap
1.80B USD
Avg Volume
31.04K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 426.51M | -5.57% |
Operating expense | 168.51M | -1.08% |
Net income | -232.78M | -717.25% |
Net profit margin | -54.58 | -764.98% |
Earnings per share | — | — |
EBITDA | 203.18M | 64.68% |
Effective tax rate | 8.92% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 367.57M | -55.35% |
Total assets | 4.68B | -10.96% |
Total liabilities | 3.08B | -67.30% |
Total equity | 1.60B | — |
Shares outstanding | 76.40M | — |
Price to book | 1.12 | — |
Return on assets | 3.00% | — |
Return on capital | 3.45% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -232.78M | -717.25% |
Cash from operations | 11.65M | -91.08% |
Cash from investing | -13.11M | -109.98% |
Cash from financing | -4.30M | 97.27% |
Net change in cash | -5.32M | 84.52% |
Free cash flow | 127.07M | -18.54% |
About
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system. Wikipedia
Founded
1920
Headquarters
Website
Employees
2,995
